243 related articles for article (PubMed ID: 38083878)
1. The highs and lows of cyclic thrombocytopenia.
Zhang H; Villar-Prados A; Bussel JB; Zehnder JL
Br J Haematol; 2024 Jan; 204(1):56-67. PubMed ID: 38083878
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations.
Zhang H; Chien M; Hou Y; Shomali W; Brar RS; Ho C; Han P; Xu D; Zhang BM; Guo X; Tolentino LL; Wu NC; Tsai AG; Jin J; Witteles WH; Chen Z; Abidi P; Jangam D; Krieger MS; Craig M; Bussel JB; Gotlib JR; Zehnder JL
Blood Adv; 2023 Jan; 7(1):190-194. PubMed ID: 35381066
[TBL] [Abstract][Full Text] [Related]
3. How I manage cyclic thrombocytopenia.
Kyrle PA; Eichinger S
Blood; 2021 Jan; 137(2):178-184. PubMed ID: 33197928
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic cyclic thrombocytopenia.
Go RS
Blood Rev; 2005 Jan; 19(1):53-9. PubMed ID: 15572217
[TBL] [Abstract][Full Text] [Related]
5. [Cyclic thrombocytopenia diagnosed by periodic platelet count measurements].
Ishikawa K; Uchida T
Rinsho Ketsueki; 2023; 64(1):66-68. PubMed ID: 36775310
[TBL] [Abstract][Full Text] [Related]
6. Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group.
Soderquist CR; Ewalt MD; Czuchlewski DR; Geyer JT; Rogers HJ; Hsi ED; Wang SA; Bueso-Ramos CE; Orazi A; Arber DA; Hexner EO; Babushok DV; Bagg A
Mod Pathol; 2018 May; 31(5):690-704. PubMed ID: 29327708
[TBL] [Abstract][Full Text] [Related]
7. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit.
Kuter DJ; Rosenberg RD
Blood; 1995 May; 85(10):2720-30. PubMed ID: 7742532
[TBL] [Abstract][Full Text] [Related]
8. Cyclic thrombocytopenia associated with estradiol: a case report.
Pang N; Li Y; Zhou K; Liu C; Yan R; Sun C; Xiao W; Ruan C; Zhai Z; Dai K
Hematology; 2023 Dec; 28(1):2240140. PubMed ID: 37493411
[TBL] [Abstract][Full Text] [Related]
9. Juvenile cyclic amegakaryocytic thrombocytopenia: a novel entity.
Bruin M; Tijssen MR; Bierings M; de Haas M
J Pediatr Hematol Oncol; 2005 Mar; 27(3):148-52. PubMed ID: 15750447
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a review.
Steensma DP; Harrison CN; Tefferi A
Leuk Lymphoma; 2001; 42(6):1243-53. PubMed ID: 11911405
[TBL] [Abstract][Full Text] [Related]
11. Coexisting driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients.
De Roeck L; Michaux L; Debackere K; Lierman E; Vandenberghe P; Devos T
Hematology; 2018 Dec; 23(10):785-792. PubMed ID: 29993347
[TBL] [Abstract][Full Text] [Related]
12. Determinants of platelet number and regulation of thrombopoiesis.
Kaushansky K
Hematology Am Soc Hematol Educ Program; 2009; ():147-52. PubMed ID: 20008193
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production.
Peck-Radosavljevic M; Wichlas M; Zacherl J; Stiegler G; Stohlawetz P; Fuchsjäger M; Kreil A; Metz-Schimmerl S; Panzer S; Steininger R; Mühlbacher F; Ferenci P; Pidlich J; Gangl A
Blood; 2000 Feb; 95(3):795-801. PubMed ID: 10648388
[TBL] [Abstract][Full Text] [Related]
14. Two patterns of thrombopoietin signaling suggest no coupling between platelet production and thrombopoietin reactivity in thrombocytopenia-absent radii syndrome.
Fiedler J; Strauss G; Wannack M; Schwiebert S; Seidel K; Henning K; Klopocki E; Schmugge M; Gaedicke G; Schulze H
Haematologica; 2012 Jan; 97(1):73-81. PubMed ID: 21933853
[TBL] [Abstract][Full Text] [Related]
15. Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression.
Moliterno AR; Williams DM; Rogers O; Spivak JL
Blood; 2006 Dec; 108(12):3913-5. PubMed ID: 16912229
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of CALR, JAK2 and MPL gene mutations in BCR-ABL negative myeloproliferative neoplasms].
Ouyang Y; Qiao C; Wang J; Xiao L; Zhang S
Zhonghua Yi Xue Za Zhi; 2015 May; 95(18):1369-73. PubMed ID: 26178351
[TBL] [Abstract][Full Text] [Related]
17. Periodic production of antiplatelet autoantibody directed against GPIIIa in cyclic thrombocytopenia.
Yanabu M; Nomura S; Fukuroi T; Kawakatsu T; Kido H; Yamaguchi K; Suzuki M; Kokawa T; Yasunaga K
Acta Haematol; 1993; 89(3):155-9. PubMed ID: 8362605
[TBL] [Abstract][Full Text] [Related]
18. The role of AGK in thrombocytopoiesis and possible therapeutic strategies.
Jiang H; Yu Z; Ding N; Yang M; Zhang L; Fan X; Zhou Y; Zou Q; Hou J; Zheng J; Zhang L; Xu Y; Liu J
Blood; 2020 Jul; 136(1):119-129. PubMed ID: 32202634
[TBL] [Abstract][Full Text] [Related]
19. Concomitant BCR-ABL1 translocation and JAK2(V617F) mutation in three patients with myeloproliferative neoplasms.
Hummel JM; Kletecka MC; Sanks JK; Chiselite MD; Roulston D; Smith LB; Czuchlewski DR; Elenitoba-Johnson KS; Lim MS
Diagn Mol Pathol; 2012 Sep; 21(3):176-83. PubMed ID: 22847163
[TBL] [Abstract][Full Text] [Related]
20. [Cyclic thrombocytopenia synchronizing with the menstrual cycle showing periodic phases of thrombocytopenia and rebound thrombocytosis].
Kurihara T; Sumi M; Kaiume H; Takeda W; Kirihara T; Sato K; Ueki T; Hiroshima Y; Kobayashi H
Rinsho Ketsueki; 2017; 58(3):243-245. PubMed ID: 28413179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
